AzTrials
AzTrials

Sensory ProfilesNCT04974229

Prognostic Factor Research of Sensory Profiles in Development of Central Sensitization

An observational study of Sensory Profiles and Central Sensitisation, run by Vrije Universiteit Brussel at 1 site in Belgium.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

A longitudinal observational cohort study to investigate the value of prognostic factors, here sensory profiles , and others, in the development of central sensitization in the low back pain population. A type 2 prognostic factor research following the PROGRESS framework. Read more about this study

Who is it for?
Ages 18 to 64 years
How many people
102 participants
Where
1 siteBelgium
Study dates
1 Jan 2016to 1 Mar 2017
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 64 years
  • All sexes
  • No healthy volunteers
  • Adult

Study population: Participants were recruited primary care physiotherapy practices randomly spread throughout the Netherlands. Participants with acute low back pain were consecutively included by physiotherapists.

Who may be able to join

  • acute low back pain (< 6 weeks)
  • with or without radiating pain
  • aged 18 to 60 years
  • a pain-free episode for at least 3 months before the onset of their current back pain
  • read and understand the Dutch language.

Who cannot join

  • previous lumbar spinal surgery
  • lumbar radicular syndrome
  • specific cause of low back pain
  • lumbar spinal stenosis
  • current malignancy
  • spondyloarthropathy
Show all 11Show fewer
  • osteoporosis
  • spondylolisthesis
  • major trauma
  • infection
  • systemic disease.

Trial locations and contacts

1 site in 1 country.

Belgium1 site
  • Vrije universiteit Brussel

    Brussels

Other trials in Belgium

About this study

Official title: Sensory Profiles as Predictors of Central Sensitization in Low Back Pain: A Prospective Cohort Study.

A longitudinal observational cohort study to investigate the value of prognostic factors, here sensory profiles , and others, in the development of central sensitization in the low back pain population. A type 2 prognostic factor research following the PROGRESS framework. Sensory profiles are identified a prognostic factors which can predict the development of central sensitization in the low back pain population.

Read the detailed description

After performing an univariable linear regression analyses the regression model predicts the dependent variable, central sensitization, significantly, and the models are significant prediction factors of the development of central sensitization. In unadjusted analyses, all four sensory profiles were significantly associated with the development of central sensitization (P<0.001).

After adjusting for pain, disability, age, and duration of low back pain, baseline sensory profiles remained significant predictors of central sensitization. On the other hand, all other predictor variables did not contribute to the prediction of central sensitization.

Being tested
In line with the Dutch guideline for non-specific low back pain, Standard usual care for non-specific low back pain was applied.
Keywords
Prognostic factors research, Sensory Profiles, Central Sensitisation, Low back pain, Nociplastic Pain
Medical subject headings
Low Back Pain, Nociplastic Pain

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • In line with the Dutch guideline for non-specific low back pain, Standard usual care for non-specific low back pain was applied.Other

    Also called In line with the Dutch guideline for low back pain, Standard usual care or non-specific low back pain was applied.

    In line with the Dutch guideline for non-specific low back pain, Standard usual care or non-specific low back pain was applied.

Study groups in NCT04974229
Study groupRoleWhat they receive
acute non-specific low back painpatients with acute low back pain of (< 6 weeks) were consecutively included with or without radiating pain, aged 18 to 60 years with a pain-free episode for at least 3 months before the onset of their current back pain. They were also required to be able to read and understand the Dutch language.
Receives: Other: In line with the Dutch guideline for non-specific low back pain, Standard usual care for non-specific low back pain was applied.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Central Sensitization Inventory score

    The validated questionnaire Central Sensitization Inventory which scores on a 5 point scale ranging from 0-100. A higher score indicated a higher degree of central sensitization.

    Measured: 12 weeks

  2. Adolescent/Adult Sensory Profile score

    Adolescent/Adult Sensory Profile measures 4 sensory profiles (sensation avoiding, sensation sensitive, sensation seeking, low registration) on ad 5 point scale, and is validated in the low back pain population. Scores range from 15-60 points per variable. A higher score means a higher degree of sensitivity for the specific sensory profile.

    Measured: 0 weeks

Secondary outcomes (4)
  1. Numeric Pain Rating Scale score

    Numeric Pain Rating Scale measures experienced level of pain, which consist of one question ranging van 0 (no pain)-10 (most extreme pain imaginable).

    Measured: Baseline (0 weeks)

  2. Pain Disability Index score

    The Pain Disability Index evaluates the effect on seven life-related domains. Each domain is measured by 1 question, with a total of 7 questions, on an 11 point scale, from 0 (no disability) to 10 (completely disabled). Previously established reliability and internal consistency are acceptable in patients with chronic pain.

    Measured: Baseline (0 weeks)

  3. age

    The included age (years) ranged from 18-60 score. A higher age indicates a worse prognoses of low back pain.

    Measured: Baseline (0 weeks)

  4. duration of low back pain

    Duration of low back pain was assessed in weeks. The included duration of low back pain ranged from 0-6 weeks. A longer duration is not better or worse.

    Measured: Baseline (0 weeks)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted23 Jul 2021
  2. Study start1 Jan 2016
  3. Primary completion1 Mar 2017
  4. Study completion1 Mar 2017

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Cross-sectional
Enrolment
102 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04974229
Sponsor's protocol ID
ProgCohSt-M15.169564
Status last verified
Jul 2021
First submitted
6 Jul 2021
Last updated
23 Jul 2021
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Sensory Profiles and Central Sensitisation, run by Vrije Universiteit Brussel at 1 site in Belgium.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 11 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 23 Jul 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Belgium. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Central Sensitization Inventory score (time frame: 12 weeks). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 Jul 2021.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in